登士柏 2025年度报告

For the fiscal year endedDecember 31, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number0-16211 DENTSPLY SIRONA Inc. Registrant’s telephone number, including area code:(844) 848-0137 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filing requirements for the past 90 days.YesNoIndicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of RegulationS-T (§ 232.405 of this chapter) during the preceding 12months (or for such shorter period that the registrant was required to submit such files). Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerginggrowth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of theExchange Act. Large Accelerated FilerAccelerated FilerNon-Accelerated FilerSmaller Reporting Company☐Emerging Growth Company☐If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control overfinancial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect thecorrection of an error to previously issued financial statements. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes☐No The aggregate market value of the voting common stock held by non-affiliates of the registrant computed by reference to the closing price as of the last business day ofthe registrant’s most recently completed second quarter ended June30, 2025, was $3,158,220,816. For purpose of this calculation only, without determining whether thefollowing are affiliates of the registrant, the registrant has assumed that (i) its directors and executive officers are affiliates, and (ii) no party who has filed a Schedule 13D or13G is an affiliate. The number of shares of the registrant’s common stock outstanding as of the close of business on February20, 2026 was 199,749,333. DOCUMENTS INCORPORATED BY REFERENCE Certain portions of the definitive Proxy Statement of DENTSPLY SIRONA Inc. (the “Proxy Statement”) to be used in connection with the 2026 Annual Meeting ofStockholders are incorporated by reference into Part III of this Form 10-K to the extent provided herein. Except as specifically incorporated by reference herein the ProxyStatement is not deemed to be filed as part of this Form 10-K. DENTSPLY SIRONA Inc.Table of Contents PART IPageItem 1Business3Item 1ARisk Factors11Item 1BUnresolved Staff Comments25Item 1CCybersecurity25Item 2Properties27Item 3Legal Proceedings27Item 4Mine Safety Disclosures28PART IIItem 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of EquitySecurities28Item 6[Reserved]29Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations30Item 7AQuantitative and Qualitative Disclosures About Market Risk42Item 8Financial Statements and Supplementary Data44Item 9Changes In and Disagreements With Accountants on Accounting and Financial Disclosure110Item 9AControls and Procedures110Item 9BOther Information110Item 9CDisclosure Regarding Foreign Jurisdiction that Prevent Inspections111PART IIIItem 10Directors, Executive Officers and Corporate Governance112Item 11Executive Compensation112Item 12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters112Item 13Certain Relationships and Related Transactions and Director Independence112Item 14Principal Accountant Fees and Services112PART IVItem 15Exhibits and Financial Statement Schedule113Item 16Form 10-K Summary118Signatures118 PART I FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS All statements included or incorporated by reference in this Form 10-K and other filings with the U.S. Securities and ExchangeCommission (the “SEC”) that do not directly and exclusively relate to historical facts constitute “forward-lo